Trial intelligence / Profile preview

Huang'e Capsules in Benign Prostatic Hyperplasia

ChiCTR-OIC-17011288Phase 4Completed

Sponsor
Zhejiang Hospital of Traditional Chinese Medicine
Start
Apr 2014
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Huang'e in benign prostatic hyperplasia (BPH), sponsored by Zhejiang Hospital of Traditional Chinese Medicine. Primary endpoint: International Prostate Symptom Score (I-PSS). Started Apr 2014; status: completed.

02

Drugs

Huang'e
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on ChiCTR-OIC-17011288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OIC-17011288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call